Opti EPA Enteric Coated
Natural health product licensed in Canada
- Licence holder
- Douglas Laboratories Canada
- NPN or DIN-HM
- 80016394
- Status
- Active licence
- Licence date
- 8 March 2010
- Revision date
- Not provided
- Form
- Gélule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Huile de poisson Source : Huile du corps d'Anchois Potency : 170 mg DHA (Docosahexaenoic acid) | Not specified | Not calculated |
| Huile de poisson Source : Huile du corps d'Anchois Potency : 330 mg EPA (Eicosapentaenoic acid) | 1,200 mg | Not calculated |
| Huile de poisson Source : Huile du corps de Sardine Potency : 170 mg DHA (Docosahexaenoic acid) | Not specified | Not calculated |
| Huile de poisson Source : Huile du corps de Sardine Potency : 330 mg EPA (Eicosapentaenoic acid) | 1,200 mg | Not calculated |
Non-medicinal ingredients
Extrait de romarin, Tocopherols, Glycérine, Palmitate d'ascorbyle, Glycerin triacetate, Eau, Gélatine, Hydroxypropylméthylcellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Gélule | 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps support cognitive health and/or brain function. Helps maintain/support cardiovascular health. To help reduce serum triglycerides/triacylglycerols. In conjunction with conventional therapy, helps to reduce the pain of rheumatoid arthritis in adults.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80016394
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.